dr. M.M.A. Kip (Michelle)

Universitair docent
BMS-TPS-HTSR
Technohal 3101
m.m.a.kip@utwente.nl
+31534896646
Visitekaartje

Dr. Michelle Kip has received her PhD (cum laude) from the University of Twente, Enschede, the Netherlands, in April 2018. Her thesis was entitled: "Early Health Technology Assessment of Point-of-Care and Laboratory Diagnostics". Currently, she works as a postdoctoral researcher at the Health Technology & Services Research Department at the University of Twente. She is experienced in the field of (early) Health Technology Assessment, and her research focuses on methods to evaluate the health economic impact of medical technologies in several phases of development, using cost-effectiveness analysis and simulation modeling. Besides evaluating the health economic impact of medical technologies, she is also experienced in the field of Multi-Criteria Decision Analysis, which includes methods to evaluate stakeholders’ preferences with regard to (new) medical technologies, as well as in expert elicitation.

During her postdoc, Michelle will work on the UCAN CAN-DU project, which aims to develop a biomarker based predictive testing approach to optimize clinical management in juvenile idiopathic arthritis compared to current standard of practice. Within this project, she will be involved in quantifying the impact of (personalized treatment strategies for) juvenile idiopathic arthritis in terms of costs and health outcomes.

Expertises

  • Medicine and Dentistry

    • Patient
    • Health Care Cost
    • Diagnosis
    • Laboratory
    • Child
    • Cost-Effectiveness Analysis
    • General Practitioner

  • Nursing and Health Professions

    • Juvenile Rheumatoid Arthritis

Organisaties

Publicaties

2024
Development of a decision support tool for biologic therapy withdrawal decisions in non-systemic juvenile idiopathic arthritisMedical decision making, 44(2), NP53-NP55. van Til, J., Kip, M., Marinescu-Muster, R., Groothuis-Oudshoorn, C., Currie, G., Benseler, S., Swart, J., Vastert, S., Wulffraat, N., Yeung, R., Marshall, D. & IJzerman, M.
2023
Quantifying hospital-associated costs, and accompanying travel costs and productivity losses, before and after withdrawing TNF-α inhibitors in juvenile idiopathic arthritisRheumatology (E-pub ahead of print/First online). Florax, A. A., Doeleman, M. J. H., de Roock, S., van der Linden, N., Schatorjé, E., Currie, G., Marshall, D. A., IJzerman, M. J., Yeung, R. S. M., Benseler, S. M., Vastert, S. J., Wulffraat, N. M., Swart, J. F. & Kip, M. M. A.https://doi.org/10.1093/rheumatology/kead688Two point-of-care test-based approaches for the exclusion of deep vein thrombosis in general practice: a cost-effectiveness analysisBMC Primary Care, 24(1), Article 42. Heerink, J. S., Nies, J., Koffijberg, H., Oudega, R., Kip, M. M. A. & Kusters, R.https://doi.org/10.1186/s12875-023-01992-zWithdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists?Pediatric rheumatology online journal, 21(1), Article 69, 69. van Til, J. A., Kip, M. M. A., Schatorjé, E. J. H., Currie, G., Twilt, M., Benseler, S. M., Swart, J. F., Vastert, S. J., Wulffraat, N., Yeung, R. S. M., Groothuis-Oudshoorn, C. G. M. K., Warta, S., Marshall, D. A. & IJzerman, M. J.https://doi.org/10.1186/s12969-023-00845-4Managing juvenile idiopathic arthritis within the context of their life: What we learnt from children and youth living with juvenile idiopathic arthritis and their parentsMusculoskeletal care, 21(4), 1248-1260. Currie, G. R., Kennedy, B. L., Benseler, S. M., R. S. M., Y., Swart, J. F., Vastert, S. J., Wulffraat, N. M., M. M. A., K., MacKean, G. & Marshall, D. A.https://doi.org/10.1002/msc.1805What matters most to pediatric rheumatologists in deciding whether to discontinue biologics in a child with juvenile idiopathic arthritis? A best-worst scaling surveyClinical rheumatology, 42(8), 2173-2180. Currie, G. R., Groothuis-Oudshoorn, C. G. M., Twilt, M., Kip, M. M. A., IJzerman, M. J., Benseler, S. M., Swart, J. F., Vastert, S. J., Wulffraat, N. M., Yeung, R. & Marshall, D. A.https://doi.org/10.1007/s10067-023-06616-6Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: A real-world data analysisRheumatology, 62(SI2), SI170-SI180. Kip, M. M. A., de Roock, S., Currie, G., Marshall, D. A., Grazziotin, L. R., Twilt, M., Yeung, R. S. M., Benseler, S. M., Vastert, S. J., Wulffraat, N., Swart, J. F. & IJzerman, M. J.https://doi.org/10.1093/rheumatology/keac299
2022
As open as possible, as closed as necessary: how to find the right balance in sharing citizen science data for health?Proceedings of Science, 418, Article 028. Wolkorte, R., Heesink, L. & Kip, M. M. A.https://pos.sissa.it/418/028/pdfFactors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritisPediatric Rheumatology, 20(1), Article 51, 1-12. Grazziotin, L. R., Currie, G., Twilt, M., IJzerman, M. J., Kip, M. M. A., Koffijberg, H., Bonsel, G., Benseler, S. M., Swart, J. F., Vastert, S. J., Wulffraat, N. M., Yeung, R. S. M., Armbrust, W., van den Berg, J. M. & Marshall, D. A.https://doi.org/10.1186/s12969-022-00713-7The societal impact of implementing an at-home blood sampling device for chronic care patients: patient preferences and cost impactBMC health services research, 22(1), Article 1529. Lingervelder, D., Kip, M. M. A., Wiese, E. D., Koffijberg, H., Ijzerman, M. J. & Kusters, R.https://doi.org/10.1186/s12913-022-08782-w

Onderzoeksprofielen

Vakken collegejaar 2023/2024

Vakken in het huidig collegejaar worden toegevoegd op het moment dat zij definitief zijn in het Osiris systeem. Daarom kan het zijn dat de lijst nog niet compleet is voor het gehele collegejaar.

Vakken collegejaar 2022/2023

Adres

Bezoekadres

Universiteit Twente

Technohal (gebouwnr. 18), kamer 3101
Hallenweg 5
7522 NH Enschede

Navigeer naar locatie

Organisaties

Scan de QR-code of
Download vCard